Long-Term Liabilities: The sum of all non-current liabilities.
Caribou Biosciences, Inc. (CRBU) had Long-Term Liabilities of $25.08M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$2.20M |
|
$-27.55M |
|
-- |
|
$2.20M |
|
$31.60M |
|
$-29.40M |
|
$1.85M |
|
$-27.55M |
|
$-27.55M |
|
$-27.55M |
|
$-27.55M |
|
$-27.55M |
|
$-27.55M |
|
$-29.40M |
|
$-29.00M |
|
93.29M |
|
93.29M |
|
$-0.30 |
|
$-0.30 |
|
| Balance Sheet Financials | |
$155.51M |
|
$7.60M |
|
$39.48M |
|
$194.98M |
|
$28.06M |
|
-- |
|
|
Long-Term Liabilities |
$25.08M |
$53.14M |
|
$141.84M |
|
$141.84M |
|
$141.84M |
|
93.47M |
|
| Cash Flow Statement Financials | |
$-90.17M |
|
$84.27M |
|
$0.75M |
|
$16.34M |
|
$11.19M |
|
$-5.15M |
|
$9.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1337.58% |
|
-1337.58% |
|
-- |
|
-1253.32% |
|
-1253.32% |
|
$-91.74M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.06 |
|
84.76 |
|
-19.42% |
|
-19.42% |
|
-14.13% |
|
-19.42% |
|
$1.52 |
|
$-0.98 |
|
$-0.97 |
|